The National Institutes of Health (NIH) has posted a grant opportunity titled "Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional)". This grant aims to stimulate HIV/AIDS research within the mission of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) that aligns with the HIV/AIDS research priorities outlined by the NIH Office of AIDS Research (OAR). The grant does not require cost sharing or matching. The funding instrument type is a grant and falls under the category of funding activity for health. The opportunity is discretionary and the CFDA number associated with it is 93.847. The eligible applicants include various institutions and organizations such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), eligible agencies of the Federal Government, faith-based or community-based organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Indian/Native American Tribal Governments (Other than Federally Recognized), non-domestic (non-U.S.) entities (Foreign Organizations), regional organizations, Tribally Controlled Colleges and Universities (TCCUs), and U.S. Territory or Possession. The grant opportunity will close on January 7, 2025, and the last updated date was February 29, 2024. For more information and to apply, interested parties can visit the following website: http://grants.nih.gov/grants/guide/pa-files/PAS-24-163.html. For any inquiries, please contact NIH Grants Information at grantsinfo@nih.gov.